Equities

Inhalerx Ltd

IRX:ASX

Inhalerx Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.036
  • Today's Change0.001 / 2.86%
  • Shares traded69.22k
  • 1 Year change-2.70%
  • Beta-1.0340
Data delayed at least 20 minutes, as of Nov 22 2024 01:54 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Inhalerx Limited is an Australia-based healthcare company. The Company is focused on developing medicinal drug-device products to address unmet medical needs in the pain management and mental health sectors. The Company partners with educators in their technical and therapeutic fields, to provide inhalation therapies that deliver added value for patients, doctors, business partners, governments, and stakeholders alike. Its Medihale Inhaler is a sealed pod inhaler designed specifically for use with inhaled formulations. It utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenic often created when combusting plant material. The sealed tamper-proof Medihale Pods provide patients with additional security. The Medihale Protective Charging Case automatically recharges the Medihale Inhaler when the inhaler is returned to its case. The Medihale Protective Charging Case even has a dedicated storage space to carry an extra Medihale c-liquid Pod.

  • Revenue in AUD (TTM)891.64k
  • Net income in AUD-756.82k
  • Incorporated2016
  • Employees--
  • Location
    Inhalerx LtdLevel 5, 126 Phillip StreetSYDNEY 2000AustraliaAUS
  • Phone+61 38395-5446
  • Websitehttps://inhalerx.com.au/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Oakridge International Ltd821.74k-761.25k1.75m----1.70--2.14-0.0433-0.04330.04650.03820.43330.89176.04---40.14-9.33-57.25-14.6559.4872.83-92.64-20.032.05-23.500.226---9.95-14.86-555.63--33.27--
VIP Gloves Ltd1.78m-13.45m2.39m4.00------1.34-0.017-0.0170.0023-0.00030.12498.281.48---94.23-20.80-164.08-35.48-98.2516.96-754.43-24.121.16-9.771.10---83.52-31.08-82.31---65.46--
Bluechiip Ltd484.69k-5.81m3.62m7.00--5.00--7.46-0.0174-0.01740.00090.00060.08850.05590.4982---106.19-56.18-350.57-75.2662.4263.81-1,199.30-827.990.2818-29.060.5065---47.03-13.91-15.31--19.38--
Osteopore Ltd2.70m-3.51m4.39m----2.41--1.63-0.0527-0.05270.0330.01570.56781.464.43---73.93---172.14--83.51---130.20--1.25-14.960.3768--31.02---16.13------
Opyl Ltd397.64k-3.13m4.61m3.00------11.59-0.0211-0.02110.0027-0.00050.7093--3.51---558.41-163.91---346.90-----787.24-272.11---7.57-----35.65-15.67-81.33------
Tali Digital Ltd146.23k-3.12m4.94m5.00--2.30--33.80-0.001-0.0010.000040.00070.0284--3.89---60.62-56.17-67.17-63.99-----2,131.60-690.28----0.00---81.28-30.68-38.01------
Global Health Limited8.67m-1.31m7.55m49.00------0.8707-0.0226-0.02260.1493-0.052.80--11.81---42.35-34.67---112.4181.1878.53-15.14-32.95---12.78----10.869.4283.71---55.12--
Adherium Ltd2.29m-10.22m7.59m----1.13--3.31-0.0275-0.02750.00620.00890.20311.051.22---90.61-110.82-129.82-157.5635.3349.25-446.19-413.922.43--0.0142---54.47-4.27-3.71---83.48--
Visioneering Technologies Inc13.23m-5.32m7.71m----1.16--0.5825-0.1205-0.12050.29140.12091.212.087.06---48.75-76.38-75.48-97.7056.7444.90-40.22-98.702.44--0.00--19.0121.3641.05------
Uscom Ltd3.77m-2.07m7.76m11.00--2.48--2.06-0.0118-0.01180.02140.01250.73160.887411.28---40.23-30.60-53.05-36.9783.8086.20-54.99-53.502.54-17.760.2443--38.730.997719.92---12.44--
Inhalerx Ltd891.64k-756.82k8.24m--------9.24-0.004-0.0040.0047-0.00031.05--2.81---88.94-80.34-252.07-99.88-----84.88-500.13---11.571.19--2,226.0922.7925.10------
Memphasys Ltd60.00k-4.44m9.70m24.00--1.11--161.62-0.004-0.0040.000050.0050.00440.3952-----32.78-19.51-54.58-25.222.67---7,403.38-12,238.500.2767-13.900.4104--290.37---30.55---21.39--
Data as of Nov 22 2024. Currency figures normalised to Inhalerx Ltd's reporting currency: Australian Dollar AUD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.